200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 117976-90-6
117976-90-6 | Rabeprazole sodium
CAS No: 117976-90-6 Catalog No: AG003U3W MDL No:MFCD02092688
Product Description
Catalog Number:
AG003U3W
Chemical Name:
Rabeprazole sodium
CAS Number:
117976-90-6
Molecular Formula:
C18H20N3NaO3S
Molecular Weight:
381.4245
MDL Number:
MFCD02092688
IUPAC Name:
sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide
InChI:
InChI=1S/C18H20N3O3S.Na/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18;/h3-4,6-9H,5,10-12H2,1-2H3;/q-1;+1
InChI Key:
KRCQSTCYZUOBHN-UHFFFAOYSA-N
SMILES:
COCCCOc1ccnc(c1C)CS(=O)c1[n-]c2c(n1)cccc2.[Na+]
Properties
Complexity:
446
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
381.112g/mol
Formal Charge:
0
Heavy Atom Count:
26
Hydrogen Bond Acceptor Count:
7
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
381.426g/mol
Monoisotopic Mass:
381.112g/mol
Rotatable Bond Count:
8
Topological Polar Surface Area:
81.5A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | Chemical research in toxicology 20150518 |
| Systematic toxicity mechanism analysis of proton pump inhibitors: an in silico study. | Chemical research in toxicology 20150316 |
| AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR. | Journal of cellular and molecular medicine 20121001 |
| Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-D-glucose (FDG) in FDG-positron emission tomography. | Surgery today 20121001 |
| Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype. | Alimentary pharmacology & therapeutics 20121001 |
| Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy. | Scandinavian journal of gastroenterology 20120901 |
| Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. | Drug metabolism and disposition: the biological fate of chemicals 20120901 |
| Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20120901 |
| Newly discovered angiogenesis inhibitors and their mechanisms of action. | Acta pharmacologica Sinica 20120901 |
| Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120801 |
| Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study. | Helicobacter 20120801 |
| Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand. | Helicobacter 20120801 |
| Rabeprazole for the treatment of acid-related disorders. | Expert review of gastroenterology & hepatology 20120801 |
| Electrical bioimpedance gastric motility measurement based on an electrical-mechanical composite mechanism. | World journal of gastroenterology 20120707 |
| Segmental changes in smooth muscle contraction as a predictive factor of the response to high-dose proton pump inhibitor treatment in patients with functional chest pain. | Journal of gastroenterology and hepatology 20120701 |
| Randomized, open-label, single-dose, crossover, relative bioavailability study in healthy adults, comparing the pharmacokinetics of rabeprazole granules administered using soft food or infant formula as dosing vehicle versus suspension. | Clinical therapeutics 20120701 |
| Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction. | World journal of gastroenterology 20120607 |
| Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. | World journal of gastroenterology 20120521 |
| A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease. | World journal of gastroenterology 20120521 |
| Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. | Journal of gastroenterology and hepatology 20120501 |
| Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring. | Journal of gastroenterology and hepatology 20120501 |
| Dose-response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes. | European journal of clinical pharmacology 20120501 |
| Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors. | Journal of gastroenterology and hepatology 20120501 |
| Predictors of acid suppression success in patients with chronic laryngitis. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20120501 |
| Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. | World journal of gastroenterology 20120407 |
| A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism. | Alimentary pharmacology & therapeutics 20120401 |
| In vitro release profile of anti-ulcer drug rabeprazole from biocompatible psyllium-PVA hydrogels. | Journal of materials science. Materials in medicine 20120401 |
| Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE study. | The American journal of gastroenterology 20120401 |
| Healing erosive esophagitis with a proton pump inhibitor: the more the merrier? | The American journal of gastroenterology 20120401 |
| [Clinical effects of dalitong granule combined proton pump inhibitors on gastroesophageal reflux disease]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120401 |
| Influence of different proton pump inhibitors on activity of cytochrome P450 assessed by [(13)C]-aminopyrine breath test. | Journal of clinical pharmacology 20120301 |
| Comparison of patients of chronic laryngitis with and without troublesome reflux symptoms. | Journal of gastroenterology and hepatology 20120301 |
| Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. | Journal of gastroenterology and hepatology 20120301 |
| Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis. | Journal of gastroenterology 20120301 |
| A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan. | Journal of gastroenterology 20120301 |
| Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. | Journal of gastroenterology 20120301 |
| Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection. | Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 20120301 |
| Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial. | Journal of gastroenterology 20120201 |
| Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. | Alimentary pharmacology & therapeutics 20120101 |
| Impact of acid inhibition on esophageal mucosal injury induced by low-dose aspirin. | Digestion 20120101 |
| The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study. | Hepato-gastroenterology 20120101 |
| Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy. | Journal of atherosclerosis and thrombosis 20120101 |
| Response to gastroesophageal reflux disease therapy: assessment at 4 weeks predicts response/non-response at 8 weeks. | Digestion 20120101 |
| Hypomagnesemia associated with a proton pump inhibitor. | Internal medicine (Tokyo, Japan) 20120101 |
| Antiprotozoal activity of proton-pump inhibitors. | Bioorganic & medicinal chemistry letters 20111215 |
| Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: a multicenter prospective observational study. | Journal of Korean medical science 20111201 |
| Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. | Gut 20111101 |
| Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan. | Journal of gastroenterology 20111101 |
| Relative bioavailability of a 5 mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers: a single-dose randomized open-label crossover study. | Current medical research and opinion 20111101 |
| A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection. | European journal of gastroenterology & hepatology 20111001 |
| Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole. | European journal of gastroenterology & hepatology 20111001 |
| Regression of multiple duodenal hyperplastic polyps following Helicobacter pylori eradication. | Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 20111001 |
| Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study. | Journal of mass spectrometry : JMS 20111001 |
| Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer. | Alimentary pharmacology & therapeutics 20110901 |
| '7, 10 and 14-days rabeprazole-based standard triple therapies for H. pylori eradication: are they still effective? A randomized trial'. | Acta gastro-enterologica Belgica 20110901 |
| Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study. | Digestive diseases and sciences 20110801 |
| A reverse method for diversity introduction of benzimidazole to synthesize H(+)/K(+)-ATP enzyme inhibitors. | Bioorganic & medicinal chemistry letters 20110715 |
| Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | Journal of medicinal chemistry 20110714 |
| Prospective, observational study using rabeprazole in 455 patients with laryngopharyngeal reflux disease. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20110601 |
| Pharmacokinetics and tolerability of rabeprazole in children 1 to 11 years old with gastroesophageal reflux disease. | Journal of pediatric gastroenterology and nutrition 20110601 |
| Efficacy of 2-week, second-line Helicobacter pylori eradication therapy using rabeprazole, amoxicillin, and metronidazole for the Japanese population. | Helicobacter 20110601 |
| The role of Acid in functional dyspepsia. | The American journal of gastroenterology 20110601 |
| Selective inactivation of a human neuronal silencing phosphatase by a small molecule inhibitor. | ACS chemical biology 20110520 |
| [A case of acute renal failure due to interstitial nephritis likely induced by rabeprazole]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20110510 |
| Rabeprazole impedes the development of reflux-induced esophageal cancer in a surgical rat model. | Digestive diseases and sciences 20110501 |
| A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection. | Journal of gastroenterology 20110501 |
| Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease. | Journal of gastroenterology 20110501 |
| Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research. | Bioanalysis 20110501 |
| Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy. | World journal of gastroenterology 20110414 |
| Relevance and characteristics of gastroesophageal reflux in adult patients with otitis media with effusion. | Auris, nasus, larynx 20110401 |
| An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers. | Alimentary pharmacology & therapeutics 20110401 |
| Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation. | Journal of clinical pharmacy and therapeutics 20110401 |
| Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. | Scandinavian journal of gastroenterology 20110301 |
| Effect of rabeprazole treatment on health-related quality of life and symptoms in patients with reflux esophagitis: a prospective multicenter observational study in Japan. | Journal of gastroenterology 20110301 |
| Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110301 |
| E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models. | Cancer research 20110215 |
| Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20110201 |
| Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20110201 |
| Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping. | Nagoya journal of medical science 20110201 |
| Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus. | Digestive diseases and sciences 20110101 |
| Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease. | Alimentary pharmacology & therapeutics 20110101 |
| Study of the pharmacokinetics and intragastric pH of rabeprazole given as successive intravenous infusion to healthy Chinese volunteers. | European journal of clinical pharmacology 20110101 |
| Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies. | Alimentary pharmacology & therapeutics 20110101 |
| Safety and efficacy of long-term maintenance therapy with oral dose of rabeprazole 10 mg once daily in Japanese patients with reflux esophagitis. | Internal medicine (Tokyo, Japan) 20110101 |
| Response to air insufflation in patients with non-erosive gastro-oesophageal reflux disease (NERD). | The Journal of international medical research 20110101 |
| Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs). | PloS one 20110101 |
| Comparison of the effects of omeprazole and rabeprazole on ticlopidine metabolism in vitro. | Journal of pharmacological sciences 20110101 |
| Effect of PPI (rabeprazole) on reflux esophagitis after total gastrectomy. | Hepato-gastroenterology 20110101 |
| Gastric wash-based molecular testing for antibiotic resistance in Helicobacter pylori. | Digestion 20110101 |
| Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: a prospective multicenter study in Japan. | Journal of gastroenterology 20101201 |
| Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. | The American journal of gastroenterology 20101201 |
| The effect of cytochrome P2C19 and interleukin-1 polymorphisms on H. pylori eradication rate of 1-week triple therapy with omeprazole or rabeprazole, amoxycillin and clarithromycin in Chinese people. | Journal of clinical pharmacy and therapeutics 20101201 |
| Enantioseparation of rabeprazole and omeprazole by nonaqueous capillary electrophoresis with an ephedrine-based ionic liquid as the chiral selector. | Biomedical chromatography : BMC 20101201 |
| Editorial: Reflux, dyspepsia, and Rome III (or Rome IV?). | The American journal of gastroenterology 20101201 |
| [Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20101201 |
| Effect of CYP2C19 genotypes on the pharmacokinetic/pharmacodynamic relationship of rabeprazole after a single oral dose in healthy Chinese volunteers. | European journal of clinical pharmacology 20101101 |
| Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults. | Clinical therapeutics 20101101 |
| Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel. | Circulation journal : official journal of the Japanese Circulation Society 20101001 |
| [A case of mucosa-associated lymphoid tissue lymphoma with penicillin allergy successfully treated with levofloxacin, minomycin and rabeprazole]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101001 |
| Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20100901 |
| Comparison of quinine and rabeprazole with quinine monotherapy in the treatment of uncomplicated falciparum malaria. | Journal of vector borne diseases 20100901 |
| Value of barium swallow studies in predicting the response to rabeprazole in elderly patients with laryngopharyngeal reflux disease and nonerosive reflux disease in particular. | The Annals of otology, rhinology, and laryngology 20100901 |
| Identification, isolation and characterization of new impurity in rabeprazole sodium. | Journal of pharmaceutical and biomedical analysis 20100801 |
| Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy. | Helicobacter 20100801 |
| How to manage Helicobacter pylori after sequential therapy failure? | Journal of clinical gastroenterology 20100701 |
| Proton-pump inhibitor as palliative care for chemotherapy-induced gastroesophageal reflux disease in pancreatic cancer patients. | Journal of palliative medicine 20100701 |
| Patients vote with their feet for 'On demand' rabeprazole in the maintenance treatment phase of reflux oesophagitis. | Alimentary pharmacology & therapeutics 20100701 |
| Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers. | Digestive diseases and sciences 20100601 |
| Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. | Journal of gastroenterology 20100601 |
| Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects. | Journal of clinical pharmacy and therapeutics 20100601 |
| Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. | European journal of gastroenterology & hepatology 20100501 |
| Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn. | Alimentary pharmacology & therapeutics 20100501 |
| Clinical trial: maintenance intermittent therapy with rabeprazole 20 mg in patients with symptomatic gastro-oesophageal reflux disease - a double-blind, placebo-controlled, randomized study. | Alimentary pharmacology & therapeutics 20100501 |
| Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia. | Journal of gastroenterology and hepatology 20100501 |
| Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole. | Acta pharmacologica Sinica 20100401 |
| Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study. | Helicobacter 20100401 |
| Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer. | Journal of the Chinese Medical Association : JCMA 20100401 |
| Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole. | Journal of clinical pharmacology 20100301 |
| Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20100301 |
| Rabeprazole 20 mg for erosive esophagitis-associated symptoms in a large, community-based study: additional results. | Digestive diseases and sciences 20100201 |
| Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole. | Digestion 20100101 |
| Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101 |
| Liquid chromatography-tandem mass/mass spectrometry method for the quantification of rabeprazole in human plasma and application to a pharmacokinetic study. | Arzneimittel-Forschung 20100101 |
| Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution? | European journal of medical research 20100101 |
| Characteristics of symptomatic reflux episodes in patients with non-erosive reflux disease who have a positive symptom index on proton pump inhibitor therapy. | Digestion 20100101 |
| Immunoglobulin E-mediated anaphylaxis to rabeprazole. | Journal of investigational allergology & clinical immunology 20100101 |
| Bioequivalence study of a fixed dose combination tablet containing rabeprazole and diclofenac sodium in healthy Indian subjects. | Arzneimittel-Forschung 20100101 |
| Spectrophotometric determination of peptic ulcer sulfur-containing drugs in bulk form and in tablets. | Drug testing and analysis 20100101 |
| Relationship between the acid-inhibitory effects of two proton pump inhibitors and CYP2C19 genotype in Japanese subjects: a randomized two-way crossover study. | The Journal of international medical research 20100101 |
| Stability-indicating TLC-densitometric method for estimation of dexrabeprazole and domperidone in pharmaceutical dosage form. | Preparative biochemistry & biotechnology 20100101 |
| The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd rescue regimen for eradication of H. pylori. | Hepato-gastroenterology 20100101 |
| The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey. | Helicobacter 20091201 |
| Efficacy and safety of rabeprazole in non-steroidal anti-inflammatory drug-induced ulcer in Japan. | World journal of gastroenterology 20091028 |
| Long-term treatment with proton pump inhibitor is associated with undesired weight gain. | World journal of gastroenterology 20091014 |
| Significant increase of esophageal mucin secretion in patients with reflux esophagitis after healing with rabeprazole: its esophagoprotective potential. | Digestive diseases and sciences 20091001 |
| Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials. | Alimentary pharmacology & therapeutics 20090915 |
| [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment]. | Zhonghua yi xue za zhi 20090915 |
| Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. | Journal of gastroenterology and hepatology 20090901 |
| Is longer duration of proton pump inhibitor trial better for gastroesophageal reflux disease-related non-cardiac chest pain? | Journal of gastroenterology and hepatology 20090901 |
| The effect of acid suppression on upper airway anatomy and obstruction in patients with sleep apnea and gastroesophageal reflux disease. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090815 |
| Long-term use of proton pump inhibitors: are they really safe? A case of delayed acute interstitial nephritis. | Journal of the American Geriatrics Society 20090801 |
| Rabeprazole: a review of its use in the management of gastric acid-related diseases in adults. | Drugs 20090709 |
| Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. | Biomedical chromatography : BMC 20090701 |
| Efficacy of a single 24-hour pre-anesthetic dose of proton pump inhibitors. | Journal of gastroenterology and hepatology 20090701 |
| Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation. | Journal of gastroenterology and hepatology 20090701 |
| Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. | Journal of gastroenterology and hepatology 20090701 |
| Interaction between clopidogrel and proton pump inhibitors. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090609 |
| Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram. | Journal of child and adolescent psychopharmacology 20090601 |
| Differential pulse polarographic investigation of lansoprazole and rabeprazole using dropping mercury electrode. | Die Pharmazie 20090601 |
| Reflux profile of Chinese gastroesophageal reflux disease patients with combined multichannel intraluminal impedance-pH monitoring. | Journal of gastroenterology and hepatology 20090601 |
| Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques. | Magnetic resonance in chemistry : MRC 20090501 |
| Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg. | Alimentary pharmacology & therapeutics 20090501 |
| Lack of modulation of gastric emptying by dietary nitrate in healthy volunteers. | The Tohoku journal of experimental medicine 20090501 |
| Treatment of Schatzki's ring. | Gastrointestinal endoscopy 20090501 |
| Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori. | British journal of clinical pharmacology 20090501 |
| Increased health costs from mandated Therapeutic Substitution of proton pump inhibitors in British Columbia. | Alimentary pharmacology & therapeutics 20090415 |
| Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules. | Journal of gastroenterology and hepatology 20090401 |
| Congenital absence of the splenic artery and splenic vein accompanied with a duodenal ulcer and deformity. | World journal of gastroenterology 20090321 |
| The role of gastroesophageal reflux in exercise-triggered asthma: a randomized controlled trial. | Digestive diseases and sciences 20090301 |
| Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori. | World journal of gastroenterology 20090221 |
| Does rabeprazole enhance distension-induced gastric accommodation? | Digestive diseases and sciences 20090201 |
| The effect of gastroesophageal flap valve appearance on the management of patients with symptoms of gastroesophageal reflux disease. | Digestive diseases and sciences 20090201 |
| Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population. | Journal of gastroenterology and hepatology 20090201 |
| A postmarketing surveillance study of dexrabeprazole in the treatment of acid peptic disorders. | Journal of the Indian Medical Association 20090201 |
| Rabeprazole: a pharmacologic and clinical review for acid-related disorders. | Expert opinion on drug safety 20090101 |
| A comparative study of proton-pump inhibitor tests for Chinese reflux patients in relation to the CYP2C19 genotypes. | Journal of clinical gastroenterology 20090101 |
| Lack of in vitro interactions using human liver microsomes between rabeprazole and anticancer drugs. | European journal of drug metabolism and pharmacokinetics 20090101 |
| In vitro antagonism of rabeprazole and metronidazole upon clinical isolates of Helicobacter pylori. | Chemotherapy 20090101 |
| Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study. | Hepato-gastroenterology 20090101 |
| High-performance thin-layer chromatographic determination of rabeprazole sodium and domperidone in combined dosage form. | Journal of AOAC International 20090101 |
| Scoring of reflux symptoms associated with scleroderma and the usefulness of rabeprazole. | Clinical and experimental rheumatology 20090101 |
| [Combined therapy of acid-dependent gastrointestinal disorders with the use of antacidic drug Relcer]. | Klinicheskaia meditsina 20090101 |
| Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study. | Digestion 20090101 |
| Pharmacokinetics and bioequivalence study of a fixed dose combination of rabeprazole and itopride in healthy Indian volunteers. | Arzneimittel-Forschung 20090101 |
| Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study. | Drug metabolism and pharmacokinetics 20090101 |
| Spectrofluorometry, thin layer chromatography, and column high-performance liquid chromatography determination of rabeprazole sodium in the presence of its acidic and oxidized degradation products. | Journal of AOAC International 20090101 |
| Negative chronotropic effect of proton pump inhibitors on frog-heart preparation. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20090101 |
| [The quality of life dynamics in patients with gastroesophageal reflux disease during rabeprazol therapy]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101 |
| It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients. | Digestive diseases and sciences 20081201 |
| A glass of water immediately increases gastric pH in healthy subjects. | Digestive diseases and sciences 20081201 |
| Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication. | Journal of gastroenterology and hepatology 20081201 |
| [Efficacy of 4 kinds of triple strategy for Helicobacter pylori eradication]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20081201 |
| Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis. | Helicobacter 20081201 |
| Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. | Helicobacter 20081201 |
| [Proton pump inhibition: more than only reflux therapy]. | MMW Fortschritte der Medizin 20081113 |
| Rabeto plus: a valuable drug for managing functional dyspepsia. | Journal of the Indian Medical Association 20081101 |
| [Rabeprazole induced acute interstitial nephritis]. | La Revue de medecine interne 20081001 |
| [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]. | Presse medicale (Paris, France : 1983) 20081001 |
| High performance liquid chromatographic analysis of rabeprazole in human plasma and its pharmacokinetic application. | Archives of pharmacal research 20080901 |
| [Effect of Helicobacter pylori eradication on patients with functional dyspepsia]. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20080901 |
| Proton pump inhibitors may increase the risk of delayed bleeding complications after open heart surgery if used concomitantly with warfarin. | The Thoracic and cardiovascular surgeon 20080801 |
| Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease. | Expert review of gastroenterology & hepatology 20080801 |
| [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801 |
| Ten mg dexrabeprazole daily is as effective as 20 mg dexrabeprazole daily. | World journal of gastroenterology 20080728 |
| Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080701 |
| Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy. | The American journal of gastroenterology 20080701 |
| Quantitative analysis of rabeprazole sodium in commercial dosage forms by spectrophotometry. | Chemical & pharmaceutical bulletin 20080701 |
| Chemometric determination of rabeprazole sodium in presence of its acid induced degradation products using spectrophotometry, polarography and anodic voltammetry at a glassy carbon electrode. | Pakistan journal of pharmaceutical sciences 20080701 |
| Gastroesophageal reflux disease as an etiology of sleep disturbance in subjects with insomnia and minimal reflux symptoms: a pilot study of prevalence and response to therapy. | Digestive diseases and sciences 20080601 |
| Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus. | Alimentary pharmacology & therapeutics 20080601 |
| Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures. | European journal of clinical investigation 20080601 |
| Intramolecular nonbonded S...N interaction in rabeprazole. | Chemical & pharmaceutical bulletin 20080601 |
| A randomized, prospective trial of electrosurgical incision followed by rabeprazole versus bougie dilation followed by rabeprazole of symptomatic esophageal (Schatzki's) rings. | Gastrointestinal endoscopy 20080501 |
| Semipreparative chiral supercritical fluid chromatography in the fractionation of lansoprazole and two related antiulcer drugs enantiomers. | Journal of separation science 20080501 |
| Recognizing doxycycline-induced esophageal ulcers in dental practice: a case report and review. | Journal of the American Dental Association (1939) 20080501 |
| Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors? | World journal of gastroenterology 20080428 |
| Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers. | World journal of gastroenterology 20080407 |
| Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation. | Journal of gastroenterology and hepatology 20080401 |
| Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype. | Digestive diseases and sciences 20080401 |
| Upper gastrointestinal bleeding in patients with acute coronary syndromes: clinical predictors and prophylactic role of proton pump inhibitors. | Journal of clinical gastroenterology 20080401 |
| HPTLC determination of rabeprazole and domperidone in capsules and its validation. | Journal of chromatographic science 20080401 |
| Rabeprazole plus domperidone: the answer for gastro-oesophageal reflux disease. | Journal of the Indian Medical Association 20080401 |
| Rapid protection of the gastroduodenal mucosa against aspirin-induced damage by rabeprazole. | Alimentary pharmacology & therapeutics 20080315 |
| The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20080315 |
| Spectrophotometric simultaneous determination of rabeprazole sodium and itopride hydrochloride in capsule dosage form. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080301 |
| In vitro metabolic stability of moisture-sensitive rabeprazole in human liver microsomes and its modulation by pharmaceutical excipients. | Archives of pharmacal research 20080301 |
| Application of instrumental evaluation of color for the pre-formulation and formulation of rabeprazole. | International journal of pharmaceutics 20080227 |
| Effect of pharmaceutical excipients on aqueous stability of rabeprazole sodium. | International journal of pharmaceutics 20080227 |
| Long-term proton pump inhibitor use in children: a retrospective review of safety. | Digestive diseases and sciences 20080201 |
| Proton pump inhibitors relieve and prevent symptoms related to gastric acidity after esophagectomy. | World journal of surgery 20080201 |
| Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection. | Journal of clinical gastroenterology 20080201 |
| Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation. | Therapeutic drug monitoring 20080201 |
| Effect of single oral dose of sodium rabeprazole on the intragastric pH & volume in patients undergoing elective surgery. | The Indian journal of medical research 20080201 |
| Structural elucidation of rabeprazole sodium photodegradation products. | Journal of pharmaceutical and biomedical analysis 20080107 |
| Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial. | The American journal of gastroenterology 20080101 |
| High-performance liquid chromatography and thin-layer chromatography for the simultaneous quantitation of rabeprazole and mosapride in pharmaceutical products. | Journal of chromatographic science 20080101 |
| Stereoselective disposition of proton pump inhibitors. | Clinical drug investigation 20080101 |
| Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5. | Drug metabolism and pharmacokinetics 20080101 |
| Column reversed-phase high-performance liquid chromatographic method for simultaneous determination of rabeprazole sodium and domperidone in combined tablet dosage form. | Journal of AOAC International 20080101 |
| Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors. | BMC gastroenterology 20080101 |
| Evaluation of upper abdominal symptoms using the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease in patients with laryngopharyngeal reflux symptoms. | Journal of gastroenterology 20080101 |
| No relationship between plasma desacyl-ghrelin levels and rabeprazole-related delay in gastric emptying : controlled study in healthy volunteers. | Drugs in R&D 20080101 |
| Prokinetics influence the pharmacokinetics of rabeprazole. | Digestion 20080101 |
| Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients : a randomized, double-blind, placebo-controlled study. | Clinical drug investigation 20080101 |
| [The first results of the program Effective Eradication in Novosibirsk]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial. | Digestive diseases and sciences 20071201 |
| Rabeprazole- versus esomeprazole-based eradication regimens for H. pylori infection. | Helicobacter 20071201 |
| Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate. | Helicobacter 20071201 |
| Maintenance treatment of gastroesophageal reflux disease: an evaluation of continuous and on-demand therapy with rabeprazole 20 mg. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20071201 |
| Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient. | Drug metabolism and pharmacokinetics 20071201 |
| Gene expression changes of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with PPI treatment: a preliminary study. | The Laryngoscope 20071101 |
| Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20071101 |
| Rabeprazole delays gastric emptying of a nutrient liquid. | Journal of gastroenterology and hepatology 20071101 |
| Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. | Digestive diseases and sciences 20071001 |
| Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. | World journal of gastroenterology 20070907 |
| Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles. | Chirality 20070901 |
| Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20070901 |
| CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor. | Pharmacogenomics 20070901 |
| Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: an open-label, single- and multiple-dose study. | Clinical therapeutics 20070901 |
| Randomized, double-blind, comparative study of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal reflux disease. | World journal of gastroenterology 20070814 |
| Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. | The American journal of gastroenterology 20070801 |
| Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease. | Journal of gastroenterology and hepatology 20070801 |
| Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy. | European journal of clinical pharmacology 20070801 |
| Recent advances in chirally pure proton pump inhibitors. | Journal of the Indian Medical Association 20070801 |
| Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. | Digestive diseases and sciences 20070701 |
| Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. | Alimentary pharmacology & therapeutics 20070701 |
| Rabeprazole and psychiatric symptoms. | The Annals of pharmacotherapy 20070701 |
| Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: an open, randomized crossover trial. | Journal of gastroenterology and hepatology 20070601 |
| [Oesophageal acid exposure test in non-erosive gastroesophageal reflux disease and the diagnostic value of rabeprazole]. | Zhonghua nei ke za zhi 20070601 |
| Case of paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated reflux esophagitis. | Fukuoka igaku zasshi = Hukuoka acta medica 20070601 |
| Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients. | Biopharmaceutics & drug disposition 20070501 |
| Liquid chromatographic-mass spectrometry analysis and pharmacokinetic studies of a novel rabeprazole formulation, sterile powder for injection, in dogs and rats. | Biopharmaceutics & drug disposition 20070501 |
| Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan. | Alimentary pharmacology & therapeutics 20070501 |
| Prediction of gastroesophageal reflux in otitis media with effusion in adults. | Acta oto-laryngologica 20070501 |
| Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004. | Journal of toxicology and environmental health. Part A 20070415 |
| [Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice]. | Orvosi hetilap 20070325 |
| Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center. | Alimentary pharmacology & therapeutics 20070315 |
| Identification and characterization of potential impurities of rabeprazole sodium. | Journal of pharmaceutical and biomedical analysis 20070312 |
| Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan. | Hepato-gastroenterology 20070301 |
| Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24-h intragastric pH in healthy volunteers. | Alimentary pharmacology & therapeutics 20070215 |
| Pharmacodynamic effects of single doses of rabeprazole 20 mg and pantoprazole 40 mg in patients with GERD and nocturnal heartburn. | Alimentary pharmacology & therapeutics 20070215 |
| Comparative drug effects: the case of GERD therapies. | Disease management : DM 20070201 |
| Kinetics of decomposition of rabeprazole sodium in aqueous solutions determined by high performance liquid chromatography. | Die Pharmazie 20070201 |
| Gastric mucosal levels of prostaglandins and leukotrienes in patients with gastric ulcer after treatment with rabeprazole in comparison to treatment with ranitidine. | The journal of medical investigation : JMI 20070201 |
| [Helicobacter pylori erradication and its relation to antibiotic resistance and CYP2C19 status]. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20070201 |
| Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus. | Endoscopy 20070201 |
| A relapse case of acute necrotizing esophagitis. | Endoscopy 20070201 |
| Simultaneous determination of rabeprazole sodium and itopride hydrochloride in capsule dosage form by spectrophotometry. | Hindustan antibiotics bulletin 20070201 |
| Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. | Alimentary pharmacology & therapeutics 20070115 |
| Severe bradycardia in a stroke patient caused by a single low dose of escitalopram. | European neurology 20070101 |
| [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer]. | Terapevticheskii arkhiv 20070101 |
| [Rabeprazole test and comparison of the effectiveness of course treatment with rabeprazole in patients with gastroesophageal reflux disease and non-coronary chest pain]. | Klinicheskaia meditsina 20070101 |
| [The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors]. | Klinicheskaia meditsina 20070101 |
| Comparative study of proton pump inhibitors for triple therapy in H. pylori eradication. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101 |
| The papilla of Vater just below the pylorus presenting as recurrent duodenal ulcer bleeding. | Internal medicine (Tokyo, Japan) 20070101 |
| [Clinical course of Helicobacter pylori associated chronic gastritis in post-eradicational period]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101 |
| [Safety of proton pump inhibitors]. | Medicina clinica 20061125 |
| [Reflux esophagitis. Step-down instead of step-up]. | MMW Fortschritte der Medizin 20061123 |
| A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study. | Alimentary pharmacology & therapeutics 20061115 |
| An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. | Alimentary pharmacology & therapeutics 20061115 |
| Liquid chromatographic/mass spectrometric assay of rabeprazole in dog plasma for a pharmacokinetic study. | Biomedical chromatography : BMC 20061101 |
| Acid-suppressive effects of rabeprazole: comparing 10mg and 20mg twice daily in Japanese Helicobacter pylori-negative and -positive CYP2C19 extensive metabolisers. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20061101 |
| Pharmacodynamic studies on PPIs: look carefully at the country of origin. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20061101 |
| Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers. | Journal of gastroenterology and hepatology 20061101 |
| Mass balance study of [14C] rabeprazole following oral administration in healthy subjects. | International journal of clinical pharmacology and therapeutics 20061101 |
| Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve. | European journal of clinical pharmacology 20061001 |
| Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. | Alimentary pharmacology & therapeutics 20061001 |
| Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment. | Scandinavian journal of gastroenterology 20061001 |
| Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole? | Scandinavian journal of gastroenterology 20061001 |
| Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects. | European journal of clinical pharmacology 20060901 |
| Comparison of the efficacy of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity of peptic ulcer diseases. | Journal of gastroenterology and hepatology 20060901 |
| Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism. | Journal of gastroenterology and hepatology 20060901 |
| Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. | Alimentary pharmacology & therapeutics 20060901 |
| Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastresophageal reflux disease. | Digestive diseases and sciences 20060901 |
| Effect of esophageal acid and prophylactic rabeprazole on performance in runners. | Medicine and science in sports and exercise 20060901 |
| 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060901 |
| Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 polymorphism in Chinese Hans. | World journal of gastroenterology 20060807 |
| Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes. | European journal of clinical pharmacology 20060801 |
| Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication. | Helicobacter 20060801 |
| Effects of sucralfate, cimetidine and rabeprazole on mucosal hydroxyproline content in healing of ethanol-hcl-induced gastric lesions. | Clinical and experimental pharmacology & physiology 20060701 |
| Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole. | Journal of clinical gastroenterology 20060701 |
| The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. | The American journal of gastroenterology 20060701 |
| Effects of rabeprazole or famotidine during cardiac surgery on perioperative gastric and esophageal pH readings. | The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20060701 |
| Development and validation of a dissolution test for rabeprazole sodium in coated tablets. | Journal of pharmaceutical and biomedical analysis 20060607 |
| Enantioselective disposition of lansoprazole and rabeprazole in human plasma. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060601 |
| Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? | European journal of clinical pharmacology 20060601 |
| Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada. | Journal of managed care pharmacy : JMCP 20060601 |
| Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20060515 |
| Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction. | Journal of pharmaceutical and biomedical analysis 20060503 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Proton pump inhibitors and acute interstitial nephritis. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060501 |
| Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting. | World journal of gastroenterology 20060428 |
| Comparison of the effects of proton pump inhibitors on human plasma adrenocorticotropic hormone and cortisol levels under the starved condition. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20060401 |
| A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. | Clinical pharmacology and therapeutics 20060401 |
| The effects of changing temperature correction factors on measures of acidity calculated from gastric and oesophageal pH recordings. | Alimentary pharmacology & therapeutics 20060301 |
| Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn. | Alimentary pharmacology & therapeutics 20060301 |
| Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status. | British journal of clinical pharmacology 20060301 |
| Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes. | British journal of clinical pharmacology 20060301 |
| Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors. | The Journal of allergy and clinical immunology 20060301 |
| Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated? | Journal of acquired immune deficiency syndromes (1999) 20060301 |
| Stereoselective metabolism of rabeprazole-thioether to rabeprazole by human liver microsomes. | European journal of clinical pharmacology 20060201 |
| Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype. | European journal of clinical pharmacology 20060201 |
| Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. | Annals of internal medicine 20060117 |
| A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20060115 |
| Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. | Alimentary pharmacology & therapeutics 20060115 |
| Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19. | Clinical pharmacology and therapeutics 20060101 |
| [A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060101 |
| Efficacy of a proton pump inhibitor given in the early postoperative period to relieve symptoms of hiatal hernia after open heart surgery. | Surgery today 20060101 |
| Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. | Journal of gastroenterology and hepatology 20060101 |
| 'Best practice' for Helicobacter pylori eradication in the primary care setting. | Irish medical journal 20060101 |
| Pharmacokinetic and pharmacodynamic population modeling of orally administered rabeprazole in healthy Chinese volunteers by the NONMEM method. | European journal of drug metabolism and pharmacokinetics 20060101 |
| Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy. | Digestion 20060101 |
| [Symptomatic high chromogranin A level associated with rabeprazole and ranitidine]. | Therapie 20060101 |
| Comparison of the effects of single and repeated oral doses of lansoprazole and rabeprazole on ambulatory 24-hour intragastric pH in healthy volunteers. | Clinical drug investigation 20060101 |
| [Rabeprazole in the treatment of acid-dependent diseases in children]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20060101 |
| Cryoablation of Barrett's esophagus: a pilot study. | Gastrointestinal endoscopy 20051201 |
| Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication. | Expert review of anti-infective therapy 20051201 |
| Rabeprazole experience in Korea; focus on CYP2C19 polymorphism. | Journal of gastroenterology and hepatology 20051201 |
| CYP2C19 genotype and the PPIs--focus on rabeprazole. | Journal of gastroenterology and hepatology 20051201 |
| Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer. | Journal of experimental & clinical cancer research : CR 20051201 |
| Idiopathic pure red cell aplasia: case report with review of literature. | South Dakota journal of medicine 20051201 |
| Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease. | Digestive diseases and sciences 20051101 |
| Development and validation of the Gastroesophageal Reflux Disease Treatment Satisfaction Questionnaire. | Digestive diseases and sciences 20051101 |
| Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051101 |
| [The impact of rabeprazole treatment on the quality of life in patients with reflux esophagitis and non-erosive reflux disease]. | Zhonghua nei ke za zhi 20051101 |
| Identification and synthesis of potential impurities of rabeprazole sodium. | Die Pharmazie 20051101 |
| [Establishment of 2nd line treatment regimen for H. pylori infection--future prospect for the application for national health insurance system in Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Recent topics on important drugs for H. pylori eradication: Rabeprazole]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Second-line eradication therapy for H. pylori infection--PPI+AMPC+MNZ triple therapy]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Investigation about 3rd line eradication of H. pylori]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20051001 |
| Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus. | Alimentary pharmacology & therapeutics 20051001 |
| Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor. | Digestive diseases and sciences 20051001 |
| The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy. | Anesthesia and analgesia 20051001 |
| Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK. | Current medical research and opinion 20051001 |
| Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050925 |
| The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. | Alimentary pharmacology & therapeutics 20050915 |
| Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050901 |
| A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences. | Digestive diseases and sciences 20050901 |
| Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors. | Allergy 20050801 |
| Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial. | The American journal of gastroenterology 20050801 |
| Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States. | Alimentary pharmacology & therapeutics 20050801 |
| Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry. | Digestive diseases and sciences 20050701 |
| Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test. | Digestive diseases and sciences 20050701 |
| Effects of antisecretory agents on angiogenesis during healing of gastric ulcers. | Journal of gastroenterology 20050701 |
| High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. | Alimentary pharmacology & therapeutics 20050615 |
| Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050601 |
| Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. | International journal of clinical practice 20050601 |
| The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study. | Alimentary pharmacology & therapeutics 20050601 |
| Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients. | Journal of gastroenterology and hepatology 20050601 |
| Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. | Drug metabolism and pharmacokinetics 20050601 |
| Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia. | World journal of gastroenterology 20050528 |
| Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa. | European journal of gastroenterology & hepatology 20050501 |
| [A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050501 |
| Rabeprazole controls GERD symptoms in a patient for whom treatment with lansoprazole failed: first report of 'cluster GERD.'. | Digestive diseases and sciences 20050501 |
| Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use? | Journal of gastroenterology 20050501 |
| A new-generation H2 receptor antagonist: quicker and stronger acid inhibition than proton pump inhibitors in the clinical setting? | Journal of gastroenterology 20050501 |
| Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers. | Xenobiotica; the fate of foreign compounds in biological systems 20050501 |
| Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment. | Alimentary pharmacology & therapeutics 20050401 |
| Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study. | Current medical research and opinion 20050401 |
| Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes. | Clinical pharmacology and therapeutics 20050401 |
| [The clinical applications of rabeprazole either alone or combined with anti-Helicobacter pylori agents in peptic ulcer patients]. | Zhonghua nei ke za zhi 20050401 |
| Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. | World journal of gastroenterology 20050321 |
| One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. | World journal of gastroenterology 20050321 |
| New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study. | Alimentary pharmacology & therapeutics 20050315 |
| Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotype in healthy Chinese subjects. | Acta pharmacologica Sinica 20050301 |
| Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery. | Circulation journal : official journal of the Japanese Circulation Society 20050301 |
| Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs. | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20050301 |
| Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme. | Irish medical journal 20050301 |
| High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225 |
| Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication. | World journal of gastroenterology 20050221 |
| Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003. | Helicobacter 20050201 |
| Rabeprazole-induced acute interstitial nephritis. | Nephrology (Carlton, Vic.) 20050201 |
| Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance. | Digestive diseases and sciences 20050201 |
| The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. | Alimentary pharmacology & therapeutics 20050115 |
| Spillover effects of restrictive drug formularies: a case study of PacifiCare in California. | The American journal of managed care 20050101 |
| Pharmacokinetics of rabeprazole following single intravenous and oral administration to healthy subjects. | International journal of clinical pharmacology and therapeutics 20050101 |
| Proton pump inhibitors: a survey of prescribing in an Irish general hospital. | International journal of clinical practice 20050101 |
| [Is anti-helicobacter therapy a rational approach in treatment of erosive and ulcerous lesions of the gastroduodenal mucosa in patients with inflamatory bowel diseases?]. | Klinicheskaia meditsina 20050101 |
| [Esomeprasol and rabeprasol effects on esophageal acidification in patients with gastroesophageal reflux disease, intensively metabolizing inhibitors of proton pump]. | Terapevticheskii arkhiv 20050101 |
| Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy. | Hepato-gastroenterology 20050101 |
| [Assessment of efficacy and safety of two modes of maintenance therapy with rabeprazole in patients with gastroesophageal reflux disease (GERD) of degrees 0 and 1]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20050101 |
| Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma. | Rapid communications in mass spectrometry : RCM 20050101 |
| [Pharmacogenomical aspects of gastroesophageal reflux disease]. | Vestnik Rossiiskoi akademii meditsinskikh nauk 20050101 |
| Validation of a capillary electrophoresis method for analysis of rabeprazole sodium in a pharmaceutical dosage form. | Journal of AOAC International 20050101 |
| Dual effects of rabeprazole on solid-phase gastric emptying assessed by the 13C-octanoate breath test. | Digestion 20050101 |
| What is potent acid inhibition, and how can it be achieved? | Drugs 20050101 |
| [Oral cavity manifestations of gastroesophageal reflux disease]. | Klinicheskaia meditsina 20050101 |
| [Utility of rabeprazole as a diagnostic test in non-erosive gastroesophageal reflux disease]. | Revista de gastroenterologia de Mexico 20050101 |
| [Results of the treatment of duodenal ulcer associated with Helicobacter pylori and combined with gastroesophageal reflux disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20050101 |
| Direct injection, column switching-liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225 |
| Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. | Alimentary pharmacology & therapeutics 20041201 |
| Bacteriostatic and bactericidal activity of rabeprazole against Helicobacter pylori. | Journal of chemotherapy (Florence, Italy) 20041201 |
| The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201 |
| Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. | Alimentary pharmacology & therapeutics 20041115 |
| Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole. | Alimentary pharmacology & therapeutics 20041101 |
| Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment. | Alimentary pharmacology & therapeutics 20041101 |
| Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders. | Alimentary pharmacology & therapeutics 20041101 |
| [Choice of proton pump inhibitors--does it play any role?]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20041021 |
| Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects. | Alimentary pharmacology & therapeutics 20041015 |
| Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha. | American journal of physiology. Gastrointestinal and liver physiology 20041001 |
| Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. | European journal of clinical pharmacology 20041001 |
| Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication: 7 vs. 14 day treatment. | Helicobacter 20041001 |
| Improvement in clinical course and laryngeal appearance in selected patients with chronic laryngitis after eight weeks of therapy with rabeprazole. | Medical science monitor : international medical journal of experimental and clinical research 20041001 |
| Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells. | Biological & pharmaceutical bulletin 20041001 |
| Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20041001 |
| Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status. | Clinical pharmacology and therapeutics 20041001 |
| [Five-day rabeprazole-based triple therapy for helicobacter pylori infection]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20041001 |
| Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease. | Journal of gastroenterology and hepatology 20040901 |
| Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease. | Medical science monitor : international medical journal of experimental and clinical research 20040901 |
| [The effect of rabeprazole on gastric pH in patients with gastric ulcer]. | Zhonghua nei ke za zhi 20040901 |
| Results of triple eradication therapy in Japanese children: a retrospective multicenter study. | Journal of gastroenterology 20040901 |
| Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness? | Alimentary pharmacology & therapeutics 20040815 |
| Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. | Drug metabolism and disposition: the biological fate of chemicals 20040801 |
| Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations. | The Journal of pharmacy and pharmacology 20040801 |
| [Primary care for GEDR]. | Nihon rinsho. Japanese journal of clinical medicine 20040801 |
| [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist]. | Nihon rinsho. Japanese journal of clinical medicine 20040801 |
| [PPI: new strategies for GERD]. | Nihon rinsho. Japanese journal of clinical medicine 20040801 |
| Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography. | Journal of separation science 20040801 |
| Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. | Alimentary pharmacology & therapeutics 20040715 |
| Seven-day therapy for Helicobacter pylori in the United States. | Alimentary pharmacology & therapeutics 20040701 |
| Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form. | Farmaco (Societa chimica italiana : 1989) 20040701 |
| [Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin]. | [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20040701 |
| [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?]. | Presse medicale (Paris, France : 1983) 20040619 |
| Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection. | Helicobacter 20040601 |
| Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040601 |
| On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction. | Digestive diseases and sciences 20040601 |
| Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder. | The Korean journal of internal medicine 20040601 |
| Health-related quality of life in patients with cardiovascular disease--the effect of upper gastrointestinal symptom treatment. | Alimentary pharmacology & therapeutics 20040515 |
| Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. | Alimentary pharmacology & therapeutics 20040501 |
| Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy. | Archives of surgery (Chicago, Ill. : 1960) 20040501 |
| The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040501 |
| Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. | Journal of pediatric gastroenterology and nutrition 20040401 |
| Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. | Alimentary pharmacology & therapeutics 20040215 |
| The effect of eight weeks of rabeprazole therapy on nitric oxide plasma level and esophageal pH and motility and motility nitric oxide plasma level in patients with erosive esophagitis. | Medical science monitor : international medical journal of experimental and clinical research 20040201 |
| High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication. | Journal of clinical gastroenterology 20040201 |
| Cost-minimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040201 |
| Review of rabeprazole in the treatment of gastro-oesophageal reflux disease. | Expert opinion on pharmacotherapy 20040101 |
| Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression. | Alimentary pharmacology & therapeutics 20040101 |
| [Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese]. | Zhonghua nei ke za zhi 20040101 |
| Bioequivalence study of rabeprazole sodium on healthy human volunteers. | Journal of the Indian Medical Association 20040101 |
| Bioequivalence evaluation of two rabeprazole enteric coated formulations in healthy Chinese volunteers. | European journal of drug metabolism and pharmacokinetics 20040101 |
| New liquid chromatographic method for determination of rabeprazole sodium in coated tablets. | Journal of AOAC International 20040101 |
| Perforated duodenal ulcer at seven years after heart-renal transplantation: a case report. | Hepato-gastroenterology 20040101 |
| [Particular features of application of proton pump inhibitors (Rabeprazole) in children with the gastroesophageal reflux disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101 |
| [Selecting variants of drug treatment of non-complicated duodenal ulcer (based on a study of results of Rabeprazole efficiency)]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101 |
| [Some comparative aspects of treating the gastroesophageal reflux disease eradication]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101 |
| [Clinical and pharmacoeconomic aspects of the antisecretory therapy of gastroesophageal refluxed disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101 |
| Effectiveness of proton pump inhibitors: beyond cost. | Reviews in gastroenterological disorders 20040101 |
| Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective. | Alimentary pharmacology & therapeutics 20031201 |
| Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole. | Journal of gastroenterology and hepatology 20031201 |
| Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. | The American journal of gastroenterology 20031201 |
| Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20031201 |
| Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer. | Journal of the Formosan Medical Association = Taiwan yi zhi 20031201 |
| Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells. | European journal of pharmacology 20031128 |
| Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude. | World journal of gastroenterology 20031115 |
| Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20031115 |
| Proton-pump inhibitors in a Navy hospital after a formulary change. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031115 |
| Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. | Alimentary pharmacology & therapeutics 20031101 |
| The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis. | Alimentary pharmacology & therapeutics 20031101 |
| [The effect of proton pump inhibitor on intragastric acidity and it relation to S-mephenytoin hydroxylase genetic polymorphism]. | Zhonghua nei ke za zhi 20031101 |
| Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. | The American journal of gastroenterology 20031101 |
| Association between nocturnal bruxism and gastroesophageal reflux. | Sleep 20031101 |
| Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031101 |
| Lactoferrin: milking ulcers? | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001 |
| Use of bovine lactoferrin for Helicobacter pylori eradication. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001 |
| [Modern approach to the therapy of gastroesophageal reflux disease]. | Voenno-meditsinskii zhurnal 20031001 |
| Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy. | Alimentary pharmacology & therapeutics 20030915 |
| Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20030915 |
| A new furoxan NO-donor rabeprazole derivative and related compounds. | Chembiochem : a European journal of chemical biology 20030905 |
| Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy? | Journal of gastroenterology and hepatology 20030901 |
| Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. | European journal of gastroenterology & hepatology 20030901 |
| [A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20030801 |
| Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages. | Journal of gastroenterology and hepatology 20030701 |
| Rabeprazole treatment attenuated Helicobacter pylori-associated gastric mucosal lesion formation in Mongolian gerbils. | Journal of gastroenterology and hepatology 20030701 |
| High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20030701 |
| Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial. | Alimentary pharmacology & therapeutics 20030701 |
| Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitor. | Alimentary pharmacology & therapeutics 20030701 |
| Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030701 |
| [All proton pump inhibitors are equally efficacious in standard dosages]. | Lakartidningen 20030619 |
| Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. | Alimentary pharmacology & therapeutics 20030615 |
| Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers. | Pharmacotherapy 20030601 |
| [In-vitro activity of rabeprazole, lansoprazole, and esomeprazole against Helicobacter pylori]. | Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 20030601 |
| Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects. | Alimentary pharmacology & therapeutics 20030501 |
| A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux. | Scandinavian journal of gastroenterology 20030501 |
| Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. | European journal of pharmacology 20030411 |
| Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20030401 |
| Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor. | Alimentary pharmacology & therapeutics 20030401 |
| Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease. | Alimentary pharmacology & therapeutics 20030401 |
| Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole. | Digestive diseases and sciences 20030401 |
| A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030401 |
| Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20030315 |
| Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo. | Alimentary pharmacology & therapeutics 20030315 |
| Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors. | Biological & pharmaceutical bulletin 20030301 |
| High eradication rates of Helicobacter pylori with a new sequential treatment. | Alimentary pharmacology & therapeutics 20030301 |
| Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux disease. | The American journal of gastroenterology 20030301 |
| Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products. | Journal of pharmaceutical and biomedical analysis 20030226 |
| Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20030215 |
| A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years. | Alimentary pharmacology & therapeutics 20030201 |
| Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics. | Xenobiotica; the fate of foreign compounds in biological systems 20030201 |
| Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders. | Digestive diseases and sciences 20030201 |
| Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance. | Alimentary pharmacology & therapeutics 20030101 |
| Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. | Alimentary pharmacology & therapeutics 20030101 |
| Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. | European journal of gastroenterology & hepatology 20030101 |
| Effects of rabeprazole sodium on gastric emptying, electrogastrography, and fullness. | Digestive diseases and sciences 20030101 |
| [Medico-economic efficacy of eradication schemes in helicobacter infections in patients with duodenal ulcers]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101 |
| Safety and efficacy of rabeprazole in gastroesophageal reflux disease: report of a multicenter study. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20030101 |
| [Combination therapy of chronic pancreatitis (double-blind, placebo-controlled, pilot studies)]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101 |
| Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens. | Journal of gastroenterology 20030101 |
| [Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease]. | Klinicheskaia meditsina 20030101 |
| An overview of proton pump inhibitors. | Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20030101 |
| [Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101 |
| [Comparative clinical and economic efficiency of new generation proton pump inhibitors in the treatment of gastroesophageal reflux]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101 |
| [Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency]. | Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20030101 |
| Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers. | Digestion 20030101 |
| High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. | Hepato-gastroenterology 20030101 |
| [Comparative effectiveness of the antisecretory action of rabeprazole and esomeprazole in people with rapid metabolism of proton pump inhibitors]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101 |
| [Comparative efficacy of proton pump inhibitors in children]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101 |
| Not a usual suspect; rabeprazole therapy presenting as a severe neuropsychiatric illness: case report. | International journal of psychiatry in medicine 20030101 |
| The pharmacology and clinical relevance of proton pump inhibitors. | Current gastroenterology reports 20021201 |
| Treatment and management of Helicobacter pylori infection. | Current gastroenterology reports 20021201 |
| Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. | Alimentary pharmacology & therapeutics 20021101 |
| Restoration of acid secretion following treatment with proton pump inhibitors. | Gastroenterology 20021101 |
| Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation. | Transplantation proceedings 20021101 |
| Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease. | Digestive diseases and sciences 20021101 |
| Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers. | Alimentary pharmacology & therapeutics 20021001 |
| Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia? | The American journal of gastroenterology 20021001 |
| A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. | Internal medicine (Tokyo, Japan) 20021001 |
| [Antisecretory effect of losec and pariet in peptic ulcer therapy]. | Voenno-meditsinskii zhurnal 20021001 |
| Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. | Die Pharmazie 20020901 |
| [The short term effect of rabeprazol versus omeprazole on symptom relief of duodenal ulcer]. | Zhonghua nei ke za zhi 20020901 |
| Proton pump inhibitors: an update. | American family physician 20020715 |
| The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole. | Anesthesia and analgesia 20020701 |
| Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype. | Journal of gastroenterology and hepatology 20020701 |
| Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). | Digestive diseases and sciences 20020701 |
| Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects. | Alimentary pharmacology & therapeutics 20020701 |
| Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs. | Managed care (Langhorne, Pa.) 20020701 |
| Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. | Alimentary pharmacology & therapeutics 20020601 |
| Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. | The American journal of gastroenterology 20020601 |
| A modification of the quininium resin test for assessing gastric acidity. | Alimentary pharmacology & therapeutics 20020501 |
| Primary hyperparathyroidism with duodenal ulcer and H. pylori infection. | Internal medicine (Tokyo, Japan) 20020501 |
| [Regeneration of the gastric epitheliocytes during treatment of duodenal ulcer with pariet]. | Voenno-meditsinskii zhurnal 20020401 |
| Review article: rabeprazole-based therapy in Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20020301 |
| Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. | Alimentary pharmacology & therapeutics 20020301 |
| Integrated acidity and rabeprazole pharmacology. | Alimentary pharmacology & therapeutics 20020301 |
| A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. | Alimentary pharmacology & therapeutics 20020301 |
| Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: is rabeprazole the culprit? | Archives of internal medicine 20020211 |
| [Dual therapy for Helicobacter pylori resistance to anti microbial agents]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Continuation of acid suppression therapy after H. pylori eradication]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Proton pump inhibitors: Rabeprazole]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| [Cause and prevention of nocturnal gastric acid breakthrough]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. | Transplantation 20020127 |
| Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. | International journal of antimicrobial agents 20020101 |
| Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis. | Alimentary pharmacology & therapeutics 20020101 |
| [Pharma-clinics medication of the month. Rabeprazole (Pariet)]. | Revue medicale de Liege 20020101 |
| The effects of rabeprazole on parietal cells and enterochromaffin-like cells in rats: a comparison with omeprazole. | Journal of gastroenterology 20020101 |
| Rabeprazole: quest for the best PPI. | Journal of gastroenterology 20020101 |
| [Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| [Regeneration of the esophagus epitheliocytes. Evaluation of pariet efficacy in the treatment of patients with reflux esophagitis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| Rabeprazole. | Journal of postgraduate medicine 20020101 |
| Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials. | BMC gastroenterology 20020101 |
| [Evaluation of efficacy, safety and tolerability rabeprazole in treatment of acid-peptic diseases ]. | Arquivos de gastroenterologia 20020101 |
| Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers. | The Journal of international medical research 20020101 |
| Patients have treatment preferences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole. | Current medical research and opinion 20020101 |
| [Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage)]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| [Seven-day antihelicobacter therapy of duodenal ulcer associated with Helicobacter pylori and prospects for treating patients]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| [Pariet in eradication therapy plans]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| Eradication therapy with rabeprazole versus omeprazole in the treatment of active duodenal ulcer. | Digestion 20020101 |
| [Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| [A case of the successful treatment of the esophageal leukoplakia with rabeprazole]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| [Clinical aspects of using pariet in treating chronic pancreatitis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| [Rhabdomyolysis during treatment with rabeprazole (Pariel), a proton pump inhibitor combined with domperidone (Peridys)]. | Therapie 20020101 |
| Duodenal mucosa-associated lymphoid tissue lymphoma treated by eradication of Helicobacter pylori: report of 2 cases including EUS findings. | Gastrointestinal endoscopy 20011201 |
| Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH. | Alimentary pharmacology & therapeutics 20011201 |
| Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20011201 |
| Helicobacter pylori eradication: do we have another ace up our sleeve? | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011201 |
| Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101 |
| Optimizing acid-suppression therapy. | Managed care (Langhorne, Pa.) 20011001 |
| [Modern means of anti-Helicobacter therapy]. | Voenno-meditsinskii zhurnal 20011001 |
| [Comparative study of proton pump inhibitors]. | Orvosi hetilap 20010909 |
| Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole. | Alimentary pharmacology & therapeutics 20010901 |
| Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism. | Alimentary pharmacology & therapeutics 20010901 |
| [Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring]. | Voenno-meditsinskii zhurnal 20010901 |
| Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism. | European journal of clinical pharmacology 20010901 |
| Cost-effectiveness of proton-pump inhibitors for maintenance therapy of erosive reflux esophagitis. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010715 |
| Acute fulminant hepatitis after treatment with rabeprazole and terbinafine. | Archives of internal medicine 20010709 |
| A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism. | Journal of gastroenterology and hepatology 20010701 |
| Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. | Clinical therapeutics 20010701 |
| Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes. | Alimentary pharmacology & therapeutics 20010601 |
| Laryngopharyngeal reflux symptoms improve before changes in physical findings. | The Laryngoscope 20010601 |
| Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori. | Helicobacter 20010601 |
| Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection. | Journal of gastroenterology and hepatology 20010601 |
| Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin. | Pharmacogenetics 20010601 |
| CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects. | Pharmaceutical research 20010601 |
| Proton pump inhibitors and their drug interactions: an evidence-based approach. | European journal of gastroenterology & hepatology 20010501 |
| New-generation proton pump inhibitors: overcoming the limitations of early-generation agents. | European journal of gastroenterology & hepatology 20010501 |
| [Safety profile of pariet clinical use (a literature review)]. | Voenno-meditsinskii zhurnal 20010501 |
| [H2 receptor antagonists and proton pump inhibitors: principles and rules of use]. | La Revue du praticien 20010415 |
| Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20010401 |
| 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study. | Zeitschrift fur Gastroenterologie 20010401 |
| [Pariet in current patterns of eradication of Helicobacter pylori infection]. | Voenno-meditsinskii zhurnal 20010401 |
| Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20010301 |
| Efficacy of rabeprazole once daily for acid-related disorders. | Digestive diseases and sciences 20010301 |
| The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. | Alimentary pharmacology & therapeutics 20010201 |
| [Selection of antibiotics and planning of eradication for H. pylori infection]. | Nihon rinsho. Japanese journal of clinical medicine 20010201 |
| [A new blocker of proton pump pariet: pharmacological properties and effectiveness of clinical application]. | Klinicheskaia meditsina 20010101 |
| Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality. | Scandinavian journal of gastroenterology. Supplement 20010101 |
| Rabeprazole: an update of its use in acid-related disorders. | Drugs 20010101 |
| Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line. | Xenobiotica; the fate of foreign compounds in biological systems 19970101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.